Atherogenic lipid stress induces platelet hyperactivity through CD36-mediated hyposensitivity to prostacyclin: the role of phosphodiesterase 3A

Prostacyclin (PGI(2)) controls platelet activation and thrombosis through a cyclic adenosine monophosphate (cAMP) signaling cascade. However, in patients with cardiovascular diseases this protective mechanism fails for reasons that are unclear. Using both pharmacological and genetic approaches we de...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Martin, Raslan, Zaher, Aburima, Ahmed, Magwenzi, Simbarashe, Wraith, Katie S., Spurgeon, Benjamin E.J., Hindle, Matthew S., Law, Robert, Febbraio, Maria, Naseem, Khalid M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049344/
https://www.ncbi.nlm.nih.gov/pubmed/31289200
http://dx.doi.org/10.3324/haematol.2018.213348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049344/
https://www.ncbi.nlm.nih.gov/pubmed/31289200
http://dx.doi.org/10.3324/haematol.2018.213348

Ejemplares similares